Cargando…

Host cell protein platform assay development for therapeutic mAb bioprocessing using mammalian cells

Detalles Bibliográficos
Autores principales:	Kochanowski, Nadine, Siriez, Gaetan, Mukankurayija, Larissa, Delangle, Aurélie, Murray-Smith, Alex, Dromer, Kevin, Mainwaring, David, Stilling, Clemens, Prang, Nadja, Malphettes, Laetitia, Gervais, Annick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685359/ http://dx.doi.org/10.1186/1753-6561-9-S9-P21

Ejemplares similares

ambr™ Mini-bioreactor as a high-throughput tool for culture process development to accelerate transfer to stainless steel manufacturing scale: comparability study from process performance to product quality attributes
por: Delouvroy, Frédéric, et al.
Publicado: (2015)

Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells
por: Kochanowski, Nadine, et al.
Publicado: (2011)

Technology transfer and scale down model development strategy for biotherapeutics produced in mammalian cells
por: Kochanowski, Nadine, et al.
Publicado: (2013)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

The Different Colors of mAbs in Solution
por: Ambrogelly, Alexandre
Publicado: (2021)

Direct analysis of mAb aggregates in mammalian cell culture supernatant
por: Paul, Albert J, et al.
Publicado: (2014)

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Characterization of mAb aggregates in a mammalian cell culture production process
por: Paul, Albert, et al.
Publicado: (2013)

Cellular tools for biosimilar mAb analysis
por: Lindemann, Carsten, et al.
Publicado: (2013)

Evolving trends in mAb production processes
por: Shukla, Abhinav A., et al.
Publicado: (2017)

State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017)

Evaluation of the advanced micro-scale bioreactor (ambr™) as a highthroughput tool for cell culture process development
por: Delouvroy, Frédéric, et al.
Publicado: (2013)

Stability enhancement in a mAb and Fab coformulation
por: Zhang, Hongyu, et al.
Publicado: (2020)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

A mAb for the detection of the antiretroviral drug emtricitabine
por: Youngpairoj, Ae S., et al.
Publicado: (2022)

Novel strategy for a high-yielding mAb-producing CHO strain (overexpression of non-coding RNA enhanced proliferation and improved mAb yield)
por: Tabuchi, Hisahiro
Publicado: (2013)

Developmental changes in heparan sulfate expression: in situ detection with mAbs
Publicado: (1992)

Conservancy of mAb Epitopes in Ebolavirus Glycoproteins of Previous and 2014 Outbreaks
por: Ponomarenko, Julia, et al.
Publicado: (2014)

Self-Interaction Chromatography of mAbs: Accurate Measurement of Dead Volumes
por: Hedberg, S. H. M., et al.
Publicado: (2015)

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
por: Kroesen, Michiel, et al.
Publicado: (2016)

Germinality does not necessarily define mAb expression and thermal stability
por: Schwaigerlehner, Linda, et al.
Publicado: (2019)

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
por: Golay, Josée, et al.
Publicado: (2020)

How to assess chemically defined media and feeds from 9 suppliers on CHO cells producing mAb
por: Polès-Lahille, Aurore, et al.
Publicado: (2013)

Macroscopic modeling of mammalian cell growth and metabolism
por: Ben Yahia, Bassem, et al.
Publicado: (2015)

Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17-1A affects mAb expression and plant stress response
por: Song, Ilchan, et al.
Publicado: (2018)

Strategies for adaptation of mAb-producing CHO cells to serum-free medium
por: Costa, A Rita, et al.
Publicado: (2011)

Successful radioimmunotherapy of established syngeneic rat colon carcinoma with (211)At-mAb
por: Eriksson, Sophie E, et al.
Publicado: (2013)

Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43
por: Kim, Soseul, et al.
Publicado: (2014)

Deamidated gluten: specific detection and characterisation with INRA-DG1 mAb
por: Tranquet, Olivier, et al.
Publicado: (2015)

Glycosylation characterization of therapeutic mAbs by top- and middle-down mass spectrometry
por: Tran, Bao Quoc, et al.
Publicado: (2015)

Plant Recycling for Molecular Biofarming to Produce Recombinant Anti-Cancer mAb
por: Kim, Deuk-Su, et al.
Publicado: (2016)

Tanezumab: a selective humanized mAb for chronic lower back pain
por: Webb, Michael P, et al.
Publicado: (2018)

Nomenclature of humanized mAbs: Early concepts, current challenges and future perspectives
por: Mayrhofer, Patrick, et al.
Publicado: (2018)

Controlling the Glycosylation Profile in mAbs Using Time-Dependent Media Supplementation
por: Radhakrishnan, Devesh, et al.
Publicado: (2017)

Striking Similarities between CDRs in Some mAbs That Neutralize COVID-19
por: Mi, Tianxiong, et al.
Publicado: (2020)

Expression and in vitro function of anti-cancer mAbs in transgenic Arabidopsis thaliana
por: Song, Ilchan, et al.
Publicado: (2020)

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
por: Wu, Mary Y, et al.
Publicado: (2023)

Treatment of Marmoset Intracerebral Hemorrhage with Humanized Anti-HMGB1 mAb
por: Wang, Dengli, et al.
Publicado: (2022)

Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB
por: Manso, Taciana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hbs6pott8qiultcbv130sd8u6h